TNF and psoriasis: The statistically significant associations of TNF inhibitors with psoriasis AEs were in line with current understanding of TNF inhibitors’ risk of psoriasis, as stated in the FDA package inserts of four of the five TNF inhibitors: certolizumab pegol12, adalimumab13, infliximab14, and etanercept15.